ENTITY

Aethlon Medical (AEMD US)

20
Analysis
Health Care • United States
Aethlon Medical, Inc. operates as a medical device company. The Company provides a platform to develop medical devices that target the selective removal of disease-promoting particles from the circulatory system. Aethlon Medical develops medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.
more
bullish•Aethlon Medical
•16 Aug 2024 05:00•Issuer-paid

Upcoming potential milestones include the submission to the Ethics Committees at a third site in Australia and one in India

Upcoming potential milestones include the submission to the Ethics Committees at a third site in Australia and one in India, possible approval...

Share
bullish•Aethlon Medical
•09 Jul 2024 01:00•Issuer-paid

Depending on how long it takes medical venues to review the Hemopurifier data & potentially approve moving forward

Depending on how long it takes medical venues to review the Hemopurifier data & potentially approve moving forward, we believe clinical...

Share
bullish•Aethlon Medical
•22 May 2024 23:00•Issuer-paid

AEMD: Data From In Vitro Study Supports Advancing Planned Oncology Clinical Trial

The in vitro testing examined the removal of EVs directly from plasma & was reviewed and examined by an independent 3rd party commercial lab...

Share
bullish•Aethlon Medical
•13 May 2024 23:00•Issuer-paid

The in vitro testing examined the removal of EVs directly from plasma & was reviewed and examined by an independent 3rd party commercial lab & by NAMSA

The in vitro testing examined the removal of EVs directly from plasma & was reviewed and examined by an independent 3rd party commercial lab...

Share
bullish•Aethlon Medical
•13 May 2024 22:01•Issuer-paid

Aethlon Medical Inc - ACHV: First Quarter Results

The in vitro testing examined the removal of EVs directly from plasma & was reviewed and examined by an independent 3rd party commercial lab...

Share
x